Glycans are known to play important roles in vertebrate development; however, it is difficult to analyze in mammals because it takes place in utero. Therefore, we used medaka (Oryzias latipes) to clarify the roles of glycans during vertebrate development. b-1,4-Galactosyltransferase is one of the key enzymes in the biosynthesis of the lactosamine structures that are commonly found on glycoproteins and glycolipids. Here, we show the essential role of b4GalT2 during medaka development. Depletion of b4GalT2 by morpholino antisense oligonucleotide injection resulted in significant morphological defects, such as shortening of the anterior-posterior axis, cyclopia, impaired somite segmentation, and head hypoplasia. In situ hybridization analyses revealed that the loss of b4GalT2 led to defective anterior-posterior axis elongation during gastrulation without affecting organizer formation. Furthermore, a cell tracing experiment demonstrated that b4GalT2 knockdown mainly affects mediolateral cell intercalation, which contributes to anterior-posterior axis elongation. A cell transplantation experiment indicated that glycans are produced by b4GalT2 cell-autonomously during gastrulation. b4GalT2 depletion also led to enhanced apoptosis; however, this does not account for the phenotypic abnormalities, as blockade of apoptosis failed to compensate for the b4GalT2 depletion. Our data suggest that b4GalT2 activity is cell-autonomously required in cells undergoing mediolateral cell intercalation, which drives extension movements during medaka gastrulation.
Introduction
Glycosylation is a major post-translational modification that regulates the functions of proteins involved in various biological events including embryogenesis. Several studies using glycosyltransferase-deficient mice have demonstrated the important roles of glycans in early mammalian development (Lowe and Marth, 2003) . For example, N-acetylglucosaminyltransferase 1 (Mgat1)-deficient mice develop morphogenic abnormalities by embryonic day (E) 9.5 and fail to survive beyond E10.5 (Campbell et al., 1995) . Additionally, UDP-GlcNAc: dolichol phosphate N-acetylgucosamine-1-phosphate transferase (GPT) deficient mice, which completely lack N-glycans, die shortly after implantation with apparent 0925-4773/$ -see front matter Ó 2009 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2009.03.004 cell degeneration among both embryonic and extraembryonic cell types (Marek et al., 1999) . These lines of evidence indicate that the N-glycans present on proteins are required for mammalian embryogenesis. Indeed, in humans, genetic diseases, the so-called congenital disorders of glycosylation (CDG), have been reported, in which a mutation in one of the glycosyltransferase genes causes morphological and functional abnormalities during embryogenesis and organogenesis (Grunewald et al., 2002) . In mammals, however, it is difficult to analyze early developmental processes in detail, because they take place in the uterus; therefore, we used medaka (Oryzias latipes), a teleost fish that is a good model of vertebrate development, to clarify the roles of glycans, especially in early development.
Convergence and extension movements are key cell movements in vertebrate morphogenesis. These movements are defined as a combination of cell migration toward the dorsal midline (convergence) and body axis elongation (extension), and are essential for sculpting the body plan during vertebrate gastrulation. The cooperation of a variety of cell movements, including directed migration, mediolateral cell intercalation, and cell shape changes, is required for the execution of convergence and extension movements (SolnicaKrezel, 2005) . Zebrafish and Xenopus embryos in which these movements have been disrupted exhibit significant morphological abnormalities, such as a shortened body axis and cyclopia. Genetic analyses of these mutants have revealed the requirement of various molecules in these movements, such as the Fgf and Wnt/PCP signaling pathway components (Heisenberg et al., 2000; Kilian et al., 2003; Shimada et al., 2008; Tada and Smith, 2000; Topczewski et al., 2001 ) and cell adhesion molecules McFarland et al., 2005; Yamamoto et al., 1998) .
The N-acetyllactosamine structure (Galb1-4GlcNAc-R) is commonly found in N-linked and O-linked glycans of glycoproteins as well as in glycolipids. It is known to be involved in galectin-mediated biological events including apoptosis and is an active carbohydrate determinant involved in cell adhesion processes (Taylor and Drickamer, 2007) . b-1,4-Galactosyltransferase (b4GalT), which catalyzes the transfer of Gal from the nucleotide sugar UDP-Gal to the acceptor sugar GlcNAc, is one of the key enzymes in the biosynthesis of this Nacetyllactosamine structure. Seven human genes that encode proteins with b4GalT activity have been cloned so far (Lo et al., 1998) . As mentioned above, N-glycosylation of proteins is essential for mammalian early development. Thus, we have focused on the b4GalT involved in the biosynthesis of N-glycan on proteins. It is known that b4GalT1, b4GalT2, and b4GalT5 are responsible for the biosynthesis of most N-glycans in mammals (Almeida et al., 1997; Sato et al., 1998) . In spite of the importance of its galactosyltransferase activity for producing glycans that contain the N-acetyllactosamine structure on proteins, b4GalT1 deficient mice can survive beyond birth and possess residual N-acetyllactosamine structures in their N-glycan (Kido et al., 1998; Lu et al., 1997) . These results suggest that another b4GalT, rather than b4GalT1, is involved in the regulation of early development.
In this study, we focused on the role of b4GalT2 during development, which has a similar substrate specificity to that of b4GalT1. Depletion of b4GalT2 by injection of morpholino antisense oligonucleotides into medaka embryos led to significant morphological defects, such as shortening of the anterior-posterior axis, cyclopia, impaired segmentation of somites, and hypoplasia of the head. We also found that these phenotypes were mainly caused by defects in the extension movement during gastrulation. Cell tracing and transplantation experiments revealed that b4GalT2 activity is cell-autonomously required in cells undergoing mediolateral cell intercalation. Finally, we demonstrated that although depletion of b4GalT2 leads to enhanced apoptotic cell death during early development, this does not fully account for the morphological defects described above, as the blockade of the apoptosis by Bcl-xL failed to rescue them.
Results

Molecular cloning and phylogenetic analysis of medaka b4GalT2
To address the roles of b-1,4-galactosyltransferase 2 (b4GalT2) in medaka development, we first cloned a cDNA encoding full-length medaka b4GalT2 (olb4GalT2, Genbank Accession No. AB282995). Medaka b4GalT2 showed amino acid identities of 90.6%, 68.7%, and 66.1% with fugu (Takifugu rubripes), human, and mouse orthologs, respectively. Multiple sequence alignment analysis with ClustalW revealed that medaka b4GalT2 contains several sequence motifs that are conserved among b4GalT (Lo et al., 1998) , such as a putative transmembrane domain (Fig. 1A, red letters) , FNRA, N(V/I)G, DVD, and WGWGGEDDD (Fig. 1A, red boxes) . The position of Cys residues was also conserved among medaka b4GalT2 and the aforementioned orthologs (Fig. 1A , yellow boxes). To further confirm that the cloned cDNA encodes a b4GalT2 ortholog, we carried out phylogenetic analysis and found that medaka b4GalT2 showed higher similarity to b4GalT2 than to any other human b4GalT (Fig. 1B) . The amino acid identity of medaka b4GalT2 to human b4GalT1, 3, and 4-7 was 49.7%, 52.6%, 45.5%, 44.4%, 36.4%, and 29.4%, respectively. These results indicate that the cDNA cloned here from medaka is a bona fide ortholog of mammalian b4GalT2.
2.2.
The spatiotemporal expression pattern of b4GalT2 during early development
The temporal expression pattern of b4GalT2 mRNA during early development was determined by quantitative RT-PCR ( Fig. 2A) . Strong expression was found in embryos at the 1-cell stage, indicating that the b4GalT2 mRNA was maternally loaded, and the expression level gradually decreased up to the bud stage and then slightly increased at the 2-somite stage. At 5 days post-fertilization (dpf), even higher expression was found than in the 1-cell stage embryos (data not shown). Next, the spatial expression pattern of b4GalT2 was determined by whole-mount in situ hybridization. We used a probe against the most divergent region among the b4GalT family members to minimize the possible cross-hybridization with mRNA encoding other b4GalT. b4GalT2 was ubiquitously expressed in blastulae to 95% epiboly embryos ( Fig. 2B-E) . At the 12-somite stage, the expression was concentrated in the midbrain, the hindbrain, and the developing eyes (Fig. 2F ). In the trunk/tail region, however, the expression was weak or almost absent (Fig. 2G) . In situ hybridization with a sense probe targeting the same region of b4GalT2 gave no signal at any stage (data not shown).
2.3.
Severe morphological abnormalities in b4GalT2-depleted embryos
To address the roles of b4GalT2 in medaka early development, we employed a loss-of-function strategy. We designed The alignment of the medaka b4GalT2 (olb4GalT2) amino acid sequence with those of fugu b4GalT2 (trb4GalT2), human b4GalT2 (hsb4GalT2), and mouse b4GalT2 (mmb4GalT2). Identical amino acid residues are boxed in blue. Red letters indicate a putative transmembrane domain (amino acids 17-33), and red boxes indicate short sequence motifs, FNRA, N (V/I) G, DVD, WGWGGEDDD, that are commonly found in the b4GalT family. Yellow boxes indicate the positions of cysteine residues that are conserved among these enzymes. The asterisk indicates a tryptophan residue that has been substituted by site-directed mutagenesis. (B) A phylogenetic dendrogram of b4GalT, constructed using ClustalW. Medaka b4GalT2 has the highest similarity to b4GalT2 among the human b4GalT. Fig. 2 -The spatiotemporal expression pattern of b4GalT2 during early medaka development. (A) Relative expression levels were determined by quantitative RT-PCR for b4GalT2. Data were normalized with b-actin at each stage and presented on a log scale. The error bars represent SD. The expression level of b4GalT2 gradually decreased up to the bud stage and then increased at the 2-somite stage. (B-G) Whole-mount in situ hybridization analysis of b4GalT2 expression. b4GalT2 mRNA was ubiquitously detected at the blastula (B), 50% epiboly (C), 80% epiboly stages (D) and 95% epiboly stage (E). At the 12-somite stage, the expression was markedly confined to the eyes and the brain (F), whereas it was observed weakly or absent in the trunk and tail (G). (B) Animal pole view; (C-F) dorsal view, animal pole is to the top; (G) lateral view, dorsal is to the top. a morpholino antisense oligonucleotide against b4GalT2 mRNA (b4GalT2 MO) and injected it into medaka embryos at the 1-cell stage. As a control, we used a morpholino oligonucleotide containing a five-base mismatch to the target site (control MO). The injection of the control MO did not lead to any obvious abnormalities (Fig. 3A , E, I, M, 96% normal, n = 100). At 2 dpf, a shortened anterior-posterior axis with hypoplasia of the head was observed (Fig. 3B and F, 86% with abnormalities, n = 100), and the segmentation of somites was also severely impaired in embryos injected with b4GalT2 MO (Fig. 3J) . At 3 dpf, cyclopia was observed in b4GalT2 MO-injected embryos (Fig. 3N) , whereas two eyes were evident in the control MO-injected embryos (Fig. 3M) , suggesting that the splitting of the eye field was defective in the b4GalT2-depleted embryos. In addition, malformation of the heart and blood vessels was seen at the same stage (compare Fig. 3M and N; arrows in Fig. 3M indicate the heart and blood vessels). These morphological abnormalities were also observed in embryos injected with another morpholino antisense oligonucleotide, b4GalT2 MO2, which has no sequence overlap with b4GalT2 MO (data not shown). To assess the antisense effect of b4GalT2 MO on galactosyltransferase activity, we measured the activity toward a glycoprotein acceptor in control MO-and b4GalT2 MO-injected embryos. At the bud stage, the activity was decreased by 56% in the b4GalT2 MO-injected embryos compared to that in the control embryos (control MO: 1.68 pmol/h/embryo; b4GalT2 MO: 0.94 pmol/h/embryo, Fig. S1 ).
To further confirm the specificity of b4GalT2 MO, we performed a complementation analysis using medaka b4GalT2 RNA. As expected, the phenotypic abnormalities observed in the b4GalT2 MO-injected embryos were almost completely rescued by co-injection of medaka b4GalT2 RNA, which lacks a binding site for b4GalT2 MO around the start codon (Fig. 3C , G, K, O, 28% with abnormalities, n = 100). Interestingly, coinjection of RNA encoding the mutant b4GalT2-W288A (Fig. 1A, asterisk) , which lacks enzymatic activity (Ramasamy et al., 2003) , failed to rescue the abnormalities (Fig. 3D , H, L, P, 90% with abnormalities, n = 40). This indicates that the b-1,4-galactosyltransferase activity of b4GalT2 is required for morphogenesis in medaka embryos. Taken together, these results suggest that the glycan(s) biosynthesized by b4GalT2 are necessary for proper patterning of medaka embryos during early development. 
2.4.
The essential role of b4GalT2 during medaka gastrulation
In order to analyze the abnormalities observed in b4GalT2-depleted embryos in more detail, we first observed the morphology of both the control and b4GalT2 MO-injected embryos during gastrulation, which is the most critical process for morphogenesis in early development. At the 30% epiboly stage (shield stage), the embryonic shield formed normally in the b4GalT2 MO-injected embryos as it did in the control MO-injected embryos ( Fig. 4A and F, black arrows) . The movements of epiboly, which drive cells vegetally, also occurred normally in the b4GalT2 MO-injected embryos (compare Fig. 4A -D with F-I, white arrowheads). At the 95% epiboly stage (the late gastrula stage), however, the b4GalT2 MO-injected embryos became much thinner than the control MOinjected embryos ( Fig. 4D and I, bar) . At the bud stage, shortening of the embryonic body along the anterior-posterior axis was apparent ( Fig. 4E and J, black arrowheads). These results indicate that b4GalT2 MO-injected embryos start to exhibit abnormal characteristics at late gastrulation.
We next carried out whole-mount in situ hybridization for various marker genes associated with early development. At the early gastrula stage, no tail (ntl) and spadetail (spt), panmesodermal markers, were expressed normally in the both control and b4GalT2 MO-injected embryos ( Fig. 5A and B) . Moreover, the expression of the two organizer marker genes chordin (chd) and goosecoid (gsc), and that of epidermis marker gene bmp2 were unaffected ( Fig. 5C -E). These results suggest that the mesoderm was properly induced and that the functional organizer was established in the b4GalT2 MO-injected embryos. The shape and size of the gsc and chd expression domains were indistinguishable between the control and b4GalT2 MO-injected embryos, indicating that prospective axial mesodermal cells were present normally in the b4GalT2-depleted embryos at the shield stage. At the segmentation stage, the gsc expression domain, which demarcates the prechordal mesendoderm (prospective prechordal plate), was observed in both the b4GalT2 MO-injected and the control MO-injected embryos ( Fig. 5F ), although the area of the gsc expression domain was smaller in the b4GalT2 MO-injected embryos than in the control MO-injected embryos at this stage. Notably, the ntl expression domain, which represents the chordamesoderm and tail bud mesoderm at this stage, was antero-posteriorly shorter and significantly disrupted in the b4GalT2 MO-injected embryos (Fig. 5G ). The expression of spt, which marks the tail bud mesoderm at this stage, was expanded in the b4GalT2 MO-injected embryos (Fig. 5H) . Next, we examined the expression of the paraxial mesodermal markers papc and myoD. However, we failed to detect these markers at the segmentation stage in the b4GalT2 MOinjected embryos (data not shown). We therefore examined the expression of dlx3, which marks the boundary between the neural and epidermal ectoderms and found that the width of the neuroectodermal region was mediolaterally broader in the b4GalT2 MO-injected embryos than that of the control embryos at the 90% epiboly stage (Fig. 5I) ; however, at the bud stage, the broadened width observed in the b4GalT2 MO-injected embryos had narrowed to a similar level to that in the control embryos, while the length along the anterior-posterior axis of the dlx3 expression domain was shortened in the b4GalT2 MO-injected embryos (Fig. 5J ). As shown in Fig 5K and L, we examined the expression of sox17a, an early endoderm marker. At the 80% epiboly stage, the expression in the control embryos was similar to that in b4GalT2-depleted embryos (Fig. 5K ), but was significantly decreased in the b4GalT2-depleted embryos at the 90% epiboly stage ( Fig. 5L ) and bud stage (data not shown). At the segmentation stage, the expression of six3 (forebrain marker) was detected in the b4GalT2-depleted embryos (Fig. 5M) , and the expression of pax2 (midbrain-hindbrain boundary marker) was reduced significantly or absent at the same stage (Fig. 5N ). In summary, at early gastrulation, cell fate specification occurred normally in the b4GalT2-depleted embryos; however, defective expression patterns clearly appeared in these embryos just before the segmentation stage, suggesting Typical embryos are shown at all stages. (F-J) Embryos injected with b4GalT2 MO; animal pole is to the top, and dorsal is to the right. Sixty-five percent, 75%, and 95% indicate 65%, 75%, and 95% epiboly stage, respectively. The white arrowheads indicate the edge of the blastoderm. At the shield stage, the embryonic shield formed normally in the b4GalT2 MO-injected embryos (compare A and F, arrows). Epiboly movements, which drive cells vegetally, also occurred normally in the b4GalT2 MOinjected embryos (A-D and F-I, white arrowheads). Early morphogenetic abnormalities were observed at the late gastrula stage. The black bars in panels (D) and (I) represent the dorsoventral width of the embryonic body. Abnormalities were apparent at the bud stage (E, J, black arrowheads). that b4GalT2 activity is essential for cellular events, such as cell movement and/or apoptosis in late gastrulae.
2.5.
The requirement of b4GalT2 for the extension movements mediated by mediolateral cell intercalation during late medaka gastrulation Multiple cell movements occur coordinately during vertebrate gastrulation (Solnica-Krezel, 2005) . In zebrafish gastrulae, directed cell migration toward the dorsal midline takes place in the lateral regions of the gastrulae, while mediolateral cell intercalation occurs in the dorsal region (Myers et al., 2002) . In zebrafish, the convergence and extension movements or mediolateral cell intercalation during gastrulation are impaired in most embryos that show a shortened anterior-posterior axis and cyclopia, despite normal dorsoventral patterning (Heisenberg et al., 2000; Kilian et al., 2003; Topczewski et al., 2001) . To study whether b4GalT2 affects cell movements during gastrulation, we performed a cell tracing experiment in medaka embryos using DMNB-caged fluorescein dextran (Kozlowski et al., 1997; Sepich et al., 2000) . Caged fluorescent dye was injected with either b4GalT2 MO or control MO into 1-cell stage embryos. At the shield stage, a population of cells was marked by UV-mediated uncaging, and the changes in their location were traced during gastrulation. When the cells in the lateralmost region were marked, normal directed dorsal migration of labeled cells was observed in the control MO-injected embryos (Fig. 6A-C) . In the b4GalT2 MO-injected embryos, the labeled cells failed to distribute anteriorly along the elongating anterior-posterior axis, although directed dorsal migration did take place (Fig. 6D-F ). These abnormal cell motilities are probably due to reduced mediolateral cell intercalation (see below). When examined in more detail by measuring the angle between the dorsal midline and the marked cells, a delay in dorsal migration was seen in the b4GalT2 MO-injected embryos at the 80% epiboly and the bud stage, but the differences were not significant, suggesting that directed dorsal migration is normal in the b4GalT2 MO-injected embryos (Fig. 6G) . Consistent with this finding, the mediolateral width of the expression domains of six3 and pax2 in the b4GalT2 MO-injected embryos at the segmentation stage were not broad compared to those in the control MO-injected embryos ( Fig. S2A and B) . The mediolateral width of the expression domain of dlx3 in b4GalT2 MO-injected embryos at the bud stage was also comparable to that in the control MO-injected embryos (Fig. 5J ). When cells in the dorsalmost region were marked, the labeled cells distributed throughout the midline as a narrow stripe along the anterior-posterior axis in the control embryos at both 80% epiboly and the bud stage ( Fig. 6H-J) . In contrast, the labeled cells in the b4GalT2 MO-injected embryos were scattered across a broader region along the anterior-posterior axis ( Fig. 6K-M ). These observations indicate that b4GalT2 is necessary for extension movement. To investigate the effect on extension movement, the distribution of labeled cells along the anterior-posterior axis was examined (Fig. 6N) . The length of the labeled cell distribution area (a in Fig. 6N , inset) was divided by the diameter of the embryo (b in Fig. 6N , inset) and plotted on a graph (Shimada et al., 2008) . At the 80% epiboly stage, the ratio was lower in the b4GalT2 MO-in- jected embryos than in the control embryos, and at the bud stage, the difference in the ratio significantly increased ( Fig. 6N ; t-test, P < 0.001). Mediolateral cell intercalation was prominently observed in the control embryos at this stage, as the labeled midline cells became mediolaterally polarized, had an elongated shape, and cohered with each other (Fig. 6O) . In contrast, the labeled cells remained round and failed to form a rigid cohesive structure in the b4GalT2 MO-injected embryos (Fig. 6P) . To directly assess the shape of the axial mesodermal cells in more detail, we injected RNA for cell membrane-targeted green fluorescent protein and observed the cells at high magnification with confocal microscopy (Fig. 7) . In the control embryos, the cells at the dorsal midline became polarized and mediolaterally elongated at the 90% epiboly stage (Fig. 7A) . On the other hand, the cells around the midline failed to elongate in the b4GalT2 MO-injected embryos (Fig. 7B) . At the segmentation stage, the notochord was clearly seen in the trunk region of the control embryos ( In contrast, at the same stage, mediolateral cell intercalation was seemingly disturbed, and many labeled cells remained round in b4GalT2 MOinjected embryos. The white symbol denotes the width of the embryonic body. Bar: 100 lm. (A,D) Lateral view, dorsal is to the right; (B, C, E, F, H-M) dorsal view, animal pole is to the top. ** P < 0.01, *** P < 0.001 compared with the control embryos according to the t-test. and E). In sharp contrast, the cells at the dorsal midline failed to form an organized structure when b4GalT2 was depleted ( Fig. 7D and F) . These results suggest that mediolateral cell intercalation, which drives the extension movements at the dorsal midline, is disturbed in b4GalT2-depleted embryos. Taken together, we concluded that b4GalT2 is essential for mediolateral cell intercalation and thus normal extension movements.
2.6.
The cell-autonomous requirement of b4GalT2 in mediolateral cell intercalation
The above observations indicated that b4GalT2 is required for mediolateral cell intercalation during late gastrulation. Various factors function in this process in either a cell-autonomous or non-cell-autonomous manner (Solnica-Krezel, 2005) . In order to examine whether b4GalT2 is cell-autonomously required for this process, we carried out transplantation experiments, as outlined in Fig. 8A . As donor embryos, we injected either Rhodamine-dextran (red) with control MO or FITC-dextran (green) with b4GalT2 MO into 1-cell stage embryos. At the shield stage, cells from the embryonic shield region of donors were aspirated, mixed, and transplanted into the corresponding region of host embryos at the same stage. As a control experiment, we injected fluorescent dyes without MO into donor embryos and transplanted the cells from these donor embryos into host embryos. At the segmentation stage, Fig. 7 -b4GalT2-depleted embryos show defective mediolateral cell intercalation. RNA encoding membranetargeted green fluorescent protein was injected in conjunction with MO into two-cell stage embryos, and the morphology of the dorsal midline tissue was observed at the cellular level using confocal microscopy. (A,B) Dorsal view at the 90% epiboly stage, animal to the top. The dorsal midline tissue is located at the region between the two white dotted lines. (C-F), Dorsal view at the segmentation stage, anterior to the top. The panels E and F show Nomarski images of the areas shown in C and D, respectively. Note that the cells are laterally elongated and the form the notochord in control embryos, but the cells at identical locations failed to acquire the necessary polarity to form an organized midline structure in the b4GalT2 MOinjected embryos. The white symbols in panels C and E denote the width of the notochord. nt, notochord; s, somite. Bars: 10 lm in all the panels. cell populations from both donor embryos were incorporated into the embryonic body axis and consequently formed a band of mediolaterally elongated cells known as 'cellular strings' in the midline tissue (n = 8/8, Fig. 8B ). In contrast, when MO-injected cells were transplanted into wild-type host embryos, the b4GalT2 MO-injected green cells failed to be incorporated into the midline tissue including notochord and instead remained round (Fig. 8C, white arrows) , whereas the control MO-injected red cells migrated into the midline tissue and showed an elongated shape (n = 10/10). As a complementary experiment, we next transplanted the donor cells into b4GalT2 MO-injected host embryos. The control cells were incorporated into the midline tissue and seemed to form an organized axial structure to some extent. In contrast, some donor cells injected with b4GalT2 MO were also incorporated into the midline tissue, but other cells were excluded from this structure (n = 10/13, Fig. 8D, arrows) . These results suggest that b4GalT2 functions cell-autonomously, but not noncell-autonomously, in the axial cells that take part in mediolateral cell intercalation during late gastrulation.
2.7.
Enhanced apoptosis in b4GalT2-depleted embryos cannot account for the defective extension movement While analyzing the phenotype of b4GalT2 MO-injected embryos, we noticed that an area appeared as a dark shadow around the embryonic body (for example, see Fig. 6E ). Closer examination revealed that this dark area contained apparently unhealthy cells that were detached from the embryonic body. Therefore, we carried out TUNEL staining of the embryos at various stages and found that a lot more apoptotic cells appeared in the b4GalT2 MO-injected embryos than in the control from the 50% epiboly stage onward (Fig. S3) . These results raise the possibility that enhanced apoptosis, not defective mediolateral cell intercalation, causes the phenotypic abnormalities observed in b4GalT2 MO-injected embryos. To test this possibility, we used Bcl-xL, a well-known inhibitor of apoptosis (Boise et al., 1993) . When Bcl-xL RNA was co-injected with b4GalT2 MO, apoptosis was efficiently blocked (Fig. S4) ; however, the phenotypic abnormalities such as the cyclopia and impaired segmentation of somites were still observed, although the head hypoplasia was partially rescued (Fig. 9A and B and data not shown) . Moreover, when the anterior-posterior length of the embryonic body was measured, it became obvious that the defective elongation caused by b4GalT2 depletion persisted even when apoptosis was blocked (Fig. 9C) . Together, these results demonstrate that although apoptotic cell death was enhanced in the b4GalT2-depleted embryos, blockade of apoptosis did not rescue the phenotypic abnormalities. Therefore, we conclude that the enhanced apoptosis observed does not fully account for the defective extension movement observed in b4GalT2-depleted embryos.
Discussion
b4GalT2 activity is cell-autonomously required for the extension movement mediated by mediolateral cell intercalation during medaka gastrulation
Gastrulation is the most critical step in morphogenesis during vertebrate development. In fish, it consists of coordinated cell movements such as epiboly, internalization, convergence, extension, and mediolateral cell intercalation (Myers et al., 2002; Solnica-Krezel, 2005) . Mediolateral cell intercalation is defined as a process arising at the dorsal Fig. 9 -Enhanced apoptosis in b4GalT2-depleted embryos cannot account for the extension defects. (A,B) Co-injection of BclxL RNA failed to rescue the phenotypic abnormalities caused by b4GalT2 depletion. Dorsal view at 1 dpf, anterior to the top. (C) Graph showing the embryonic body length/animal-vegetal length (AVL) ratio, as determined by morphometric analysis in control embryos (n = 29, blue), Bcl-xL RNA-injected embryos (n = 27, red), b4GalT2 MO-injected embryos (n = 30, yellow), embryos co-injected with b4GalT2 MO and 250 pg or 25 pg Bcl-xL RNA (n = 31 and 26, green and purple, respectively). b4GalT2 MO-injected embryos exhibited defective elongation (P < 0.001compared with control in t-test). Co-injection of Bcl-xL RNA at either dose failed to rescue this defect (P < 0.001 compared with the control according to the t-test at both doses; no statistical significance between the b4GalT2 MO-injected embryos and embryos co-injected with b4GalT2 MO and Bcl-xL RNA). midline, in which cells are morphologically transformed into a mediolaterally elongated shape, and these cells then intercalate with their neighboring cells. This in turn drives convergence and extension movements, resulting in narrowing of embryonic tissues mediolaterally and their anterior-posterior elongation, respectively (Keller et al., 2000) . In this study, we demonstrated that b4GalT2 activity plays essential roles during gastrulation in cells undergoing mediolateral cell intercalation. The lines of evidence supporting our idea are as follows. First, the morphological defects observed in the b4GalT2-depleted embryos were rescued by co-injection of wild-type b4GalT2 RNA, but not by mutant b4GalT2 RNA encoding the enzyme without b-1,4-galactosyltransferase activity (Fig. 3) , demonstrating that enzymatic activity is essential for this process. Second, b4GalT2-depleted medaka embryos showed a shortened body axis (Fig. 6) , and direct assessment of cell shape in the midline tissue using confocal microscopy revealed that the axial cells of the b4GalT2-depleted embryos failed to mediolaterally elongate to form the notochord, which is indicative of impaired mediolateral cell intercalation. (Fig. 7) . These observations indicate that the extension movement mediated by cell intercalation is defective in these embryos. Mesoderm induction and organizer formation appeared to occur normally in the b4GalT2-depleted embryos (Fig. 5) , which is consistent with the observation that b4GalT2 is specifically required for cellular behavior during late gastrulation (Fig. 4) . Finally, b4GalT2-depleted cells failed to contribute to the midline tissue when transplanted into wild-type host embryos (Fig. 8) . This indicates that b4GalT2 is cell-autonomously required for mediolateral cell intercalation during the extension movement. Thus, we conclude that b4GalT2 activity is essential in cells undergoing mediolateral cell intercalation during medaka gastrulation. Considering that the size of the b4GalT2 MO-injected embryos was much smaller than that of the control embryos (Figs. 3 and 4) , together with the observation that there are cells which seem to be detached from the embryonic body (see Fig. 6E ; dark shadows around the forming embryonic body represent apparently unhealthy cells), it is also possible that increased apoptosis and/or retardation of cell proliferation may occur in the absence of b4GalT2 to contribute to the observed phenotype. We therefore carried out TUNEL staining of the embryos and found that apoptotic cell death was indeed enhanced in the b4GalT2-depleted embryos. However, the enhanced apoptosis could not have been the main cause of the phenotypic defects of b4GalT2-depleted embryos, as these defects were still observed when apoptosis was efficiently blocked by co-injection of Bcl-xL RNA (Fig. 9 ).
3.2.
A comparison of b4GalT2-depleted embryos with zebrafish and medaka mutants showing similar phenotypes
In this study, we used medaka as a model organism and found that the mediolateral cell intercalation and extension movements are impaired in b4GalT2-depleted embryos. The molecular mechanisms underlying gastrulation movements have been investigated by the use of various zebrafish mutants showing defective morphogenesis during this process. The basic mechanisms governing the gastrulation process seem to be widely well-conserved among vertebrates. In medaka and zebrafish, both teleost fish, these processes are quite similar (Solnica-Krezel, 2005; Trinkaus, 1998; Trinkaus et al., 1992) . Therefore, we can discuss the possible cause of the phenotype found in the b4GalT2-depleted medaka embryos in the light of our knowledge of zebrafish mutants that show similar abnormalities in embryogenesis including during the process of convergence and extension movements.
The components of the Wnt/planar cell polarity (PCP) pathway are conceivable candidates to be affected in b4GalT2-depleted embryos, as the genetic mutation of the components of this pathway also causes abnormalities in mediolateral cell intercalation and convergence and extension movements. In this pathway, the binding of secreted glycoprotein ligands (Wnt5 or Wnt11) to their cognate receptor leads to cytoskeletal rearrangement mediated by small GTPases such as RhoA, Rac1 and, Cdc42. Cytoskeleton rearrangement regulated by the Wnt/PCP pathway is required for cells to acquire polarity and undergo morphological transformation into an elongated shape (Mlodzik, 1999; Winter et al., 2001 ). In the zebrafish mutants wnt5/pipetail (ppt) and wnt11/ silverblick (slb), mediolateral cells fail to acquire the polarity required for proper mediolateral cell intercalation, resulting in shortening of the body axis and cyclopia (Heisenberg et al., 2000; Kilian et al., 2003; Lele et al., 2001 ). In addition, mutants of other components of the Wnt/PCP pathway downstream of wnt5/11, such as dsh, prickle1, and rock2, share similar abnormalities (Heisenberg et al., 2000; Marlow et al., 2002; Veeman et al., 2003) . Importantly, mesoderm induction and organizer formation remain intact in these mutants. These phenotypes are very similar to that of b4GalT2-depleted embryos, in which mediolateral cell intercalation is disrupted. Therefore, it is possible that b4GalT2 also plays a regulatory role in the Wnt/PCP pathway, although it is currently unclear where and how this enzyme could be integrated into the pathway.
However, it should be noted that there are some differences between the Wnt/PCP pathway mutants and b4GalT2-depleted embryos. For example, the expression of paraxial mesoderm markers such as myoD and papc was not detected at the early segmentation stage in these embryos (data not shown). In addition, b4GalT2-depleted embryos showed relatively normal convergence of the lateral mesoderm while its extension was more severely defective (see Fig. 6 ). These results, coupled with the observation that the prechordal plate in b4GalT2-depleted embryos seems to be smaller than that in the control embryos (see Fig. 5 ), suggests impairment of the anterior migration of the mesendoderm in b4GalT2-depleted embryos besides extension movement defects.
The medaka maternal-zygotic mutant for fibroblast growth factor receptor 1 (fgfr1) exhibits a phenotypic resemblance to b4GalT2-depleted embryos (Shimada et al., 2008) . In this mutant, anterior migration of the axial mesoderm is disrupted, and the expression of axial and paraxial mesoderm markers is diminished at the segmentation stage, indicating that signaling through Fgfr1 is required for this process. For extension of the embryonic body, the coordinated execution of anterior migration and cell intercalation at the axial mesendoderm, including the prospective prechordal plate and notochord, is essential. The phenotypes observed in the trunk-tail region of the b4GalT2-depleted embryos and fgfr1 mutants are quite similar and are caused by defective extension movements in both cases, although there are marked differences in their overall phenotypes (Shimada et al., 2008) . Interestingly, we found that the expression of sprouty4, a well-established target gene for Fgf signaling, was downregulated in the b4GalT2-depleted embryos at the 90% epiboly stage, when mediolateral cell intercalation is actively taking place (Fig. S2C) . This suggests that Fgf signaling is somehow weakened in the absence of b4GalT2, although it is possible that the development of the tissues with sprouty4 expression was disturbed.
To test the possibilities described above, we co-injected b4GalT2 MO and constitutively active (ca-) RhoA, ca-Rac1, or ca-cdc42 RNA, which functions downstream of the noncanonical Wnt signaling pathway (Choi and Han, 2002; Habas et al., 2003 Habas et al., , 2001 Penzo-Mendez et al., 2003) or ca-H-Ras RNA, which acts downstream of the Fgf signaling pathway (Umbhauer et al., 2000) . As a result, the co-injection of all tested RNA could not rescue the abnormal phenotype observed in the b4GalT2-depleted embryos (data not shown).
As mentioned above, b4GalT2-depleted embryos seem to exhibit complex abnormalities resulting from defects in several elementary steps such as cell motility, cell-cell interactions, and apoptosis during embryogenesis, because depletion of b4GalT2 alters the glycosylation of many glycoproteins. Basically, the loss-of-function approach of glycosyltransferases makes it more difficult to address the roles of glycans, especially in signaling pathways during vertebrate development. In spite of this, our data highlighted that b4GalT2 is mainly involved in regulating mediolateral cell intercalation and extension movement during medaka gastrulation. Furthermore, our findings also raise the possibility of a connection between b4GalT2 activity and the Wnt/PCP and Fgf signaling pathways. We believe that understanding the function of glycans in particular signaling pathways will bring new insights into the study of developmental biology; however, their roles in signaling pathways during vertebrate development are largely unknown.
3.3.
How does b4GalT2 regulate mediolateral cell intercalation at the molecular level?
Members of the b4GalT family catalyze the transfer of Gal from UDP-Gal to GlcNAc on nascent glycoconjugates, although each member of the family has a different acceptor substrate specificity (Hennet, 2002) . The substrate specificity of mammalian b4GalT2 has been studied in detail and it has been shown to be involved in the biosynthesis of N-glycans on proteins (Almeida et al., 1997; Sato et al., 1998) . In this study, we demonstrated that the galactosyltransferase activity of b4GalT2 is indispensable for mediolateral cell intercalation and thus extension movement, suggesting that the Nglycans biosynthesized by b4GalT2 have important roles in these processes. In zebrafish, there are several reports in which a link between glycans and convergence and extension is suggested. For example, the mutant of knypek/glypican4, which encodes a member of the membrane-bound type of heparansulfate proteoglycans, exhibits features of convergence and extension disorder, such as a shortened body axis and broadened axial tissue (Topczewski et al., 2001 ). Embryos injected with MO for hyaluronan synthase 2 (has2) also display deficiencies in directed cell migration during gastrulation, though axial tissue extension occurs normally. Has2 is an enzyme that is necessary for biosynthesis of the glycosaminoglycan hyaluronan, a high molecular weight extracellular polysaccharide (Bakkers et al., 2004) . However, it seems unlikely that b4GalT2 is involved in the biosynthesis of glycans affected in these mutants and morphants, since b4GalT2 has specificity towards N-glycans as mentioned above. Therefore, disruption of glycosylation in these glycoproteins, which are already known to regulate convergence and extension, would not account for the defects observed in b4GalT2-depleted embryos. As mentioned above, the Fgf signaling pathway could be modified in a glycan-dependent manner, as Fgfr1 is an Nglycosylated protein, and the glycans are known to determine its signaling efficiency by altering its interaction with its ligand and the heparansulfate co-receptor (Duchesne et al., 2006) . It is also possible that the Wnt/PCP pathway is modified, as N-glycans are essential for the secretion of Wnt-3a and -5a from cultured cells (Komekado et al., 2007; Kurayoshi et al., 2007) . Based on the mutant phenotype and its glycosylation properties, cell adhesion molecules, such as cadherins and protocadherins, could also be affected in b4GalT2 MO-injected embryos. It was reported that E-cadherin is expressed in dorsal tissue at the gastrulation stage (Shimizu et al., 2005) , and its ability to form homodimers depends on N-glycosylation (Liwosz et al., 2006; Zhao et al., 2007) . It would be interesting to examine if the glycans on E-cadherin are altered in b4GalT2 MO-injected embryos.
Recently, it was reported that zebrafish embryos in which b4GalT1 expression had been depleted by MO injection also exhibit defective convergence and extension (Machingo et al., 2006) . The zebrafish b4GalT1 shows the highest sequence similarity to b4GalT1 among the human b4GalT family, whereas medaka b4GalT2 shows the highest sequence similarity to human b4GalT2. Additionally, in zebrafish, there is a gene, which has a higher similarity to medaka b4GalT2 than to zebrafish b4GalT1 (Machingo et al., 2006) . The nucleotide sequence of the gene (zebrafish b4GalT2; Genbank Accession No. NM_001128385) considerably differs from that of zebrafish b4GalT1. A phylogenetic analysis among the three genes (medaka b4GalT2, zebrafish bGalT1 and b4GalT2) also demonstrated that medaka b4GalT2 is closer to zebrafish b4GalT2 than to zebrafish b4GalT1. Therefore, the cloned b4GalT, medaka b4GalT2 is not the ortholog of zebrafish b4GalT1 but rather that of zebrafish b4GalT2. Among the human b4GalT family, however, b4GalT1 and b4GalT2 are the closest subtypes in terms of both amino acid sequence and substrate specificity. Moreover, medaka b4GalT2 and zebrafish b4GalT1 display almost identical expression patterns, and the phenotypic features observed in respective MO-injected embryos are similar. Therefore, these two distinct b4GalT may partially share substrates involved in early development and function coordinately in this process. In fact, we found that medaka b4GalT1 is expressed at both the blastula and gastrula stages (data not shown). We thus performed a rescue experiment in which mouse b4GalT1 RNA was co-injected with b4GalT2 MO. This resulted in the suppression of loss of the b4GalT2 phenotype, suggesting that mouse b4GalT1 is able to compensate for the loss of b4GalT2 when overexpressed (Fig. S5) . Despite the close substrate specificity shared by b4GalT1 and b4GalT2 in mammals, it is also reported that there are some differences. For example, in humans, the galactosyltransferase activity of b4GalT2 against O-fucosylated glycans is higher than that of b4GalT1 (Sasaki et al., 2005) . In the future, identification of the substrates of b4GalT2 is essential, as it would provide a more detailed understanding of the role of glycans during gastrulation.
In conclusion, we have demonstrated that b4GalT2 is required for proper mediolateral cell intercalation and thus extension movement during medaka gastrulation. b-1,4-Galactosyltransferase activity is cell-autonomously required in this context, suggesting that the glycans synthesized by this enzyme are essential for these processes. Identification of the target molecules that carry these glycans will lead to better understanding of the novel roles of b-1,4-galactosylated glycans during early vertebrate development.
4.
Materials and methods
Medaka maintenance, embryo production and staging
Medaka of the d-rR strain were maintained under an artificial photoperiod of 14L:10D, at an ambient temperature of 27˚C. Embryos were produced by natural mating and staged according to morphology as described (Iwamatsu, 2004 
Quantitative RT-PCR
Fifty embryos from each stage were harvested and lysed in TRIzol for total RNA extraction. Total RNA was digested with DNaseI before the PCR to prevent genomic DNA contamination. One microgram of total RNA was used per 25 ll reaction. The PCR was performed with a Chromo 4 Real-Time System (Bio-Rad, Hercules, CA) using SYBR green I. The primers used were as follows:
Each sample was run in triplicate and then averaged. Quantification of relative expression was carried out using b-actin expression as a standard.
4.4.
RNA and morpholino oligonucleotides injection and TUNEL staining Capped RNA was synthesized using a RiboMax large scale RNA production kit (Promega). After the reaction, synthesized RNA was purified using the RNeasy Mini Kit (Qiagen, Hilden, Germany) and diluted with RNase-free water to a final concentration of 400 ng/ll (medaka b4GalT2 and mut b4GalT2). RNA (200 pg) was injected into the cells of one-to two-cellstage embryos. For the Bcl-xL, mouse b4GalT1, constitutively active (ca-) RhoA, ca-Rac1, ca-Ras, and ca-Cdc42 RNA coinjection experiments, RNA were synthesized, respectively, as above and injected at the dose described. Morpholino antisense nucleotides (MOs) were designed to bind to sequences flanking and including the initiating methionine codon and obtained from Gene Tools, LLC (Philomath, OR). The sequences of the MO were as follows (the sequence complementary to the predicted start codon is underlined): b4GalT2 MO: 5 0 -CGTCCCAACATCAGCCGGGTCATGG-3 0 , b4GalT2 MO2:
CGTCCgAAgATCAaCCGGGTgATcG-3 0 . MO were dissolved and diluted in Yamamoto's Ringer solution (Yamamoto, 1954) , and 4 ng were injected into the cells of one-to two-cell-stage embryos. TUNEL staining was carried out using the DeadEnd Fluorometric TUNEL system (Promega) according to the manufacturer's instructions.
Site-directed mutagenesis of b4GalT2
Trp288 (indicated by asterisks in Fig. 1A ) in b4GalT2 was substituted for Ala according to the procedure described previously (Ramasamy et al., 2003) . The following primers were used for site-directed mutagenesis: 5 0 -GAGTACTGGG CGCGGGGGGGGAGGAC-3 0 and 5 0 -GTCCTCCCCCCCCGCGCCCC AGTACTC-3 0 (the Ala codon introduced is underlined).
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as described (Loosli et al., 1998) . Briefly, staged embryos were fixed in 4% paraformaldehyde and dehydrated in methanol. Following rehydration in phosphate-buffered saline/0.1% Tween 20, the embryos were prehybridized for 2 h at 65˚C. Hybridization with gene-specific probes was conducted overnight at 65˚C. DIG-labeled probes were detected with anti-DIG antibody (Roche, Basel, Switzerland) and visualized with BM purple (Roche). The following antisense digoxigenin-labeled probes were used: no tail (Araki et al., 2001) , bmp2 (medaka EST Database, Accession No. MF01SSA199F01), spadetail (MF01SSA103E01), goosecoid (MF015DA014K11), six3 (MF015DA 006K02), pax2 (MF01SSA182E11), chordin (Ensembl Accession No. ENSORLT00000011913, nucleotide sequence 1577-2135), sox17a (MF01SSA074A09), papc (ENSORLT00000022242), and b4GalT2 (nucleotide sequence 39-542). The probes were synthesized using a DIG RNA labeling Kit T7/SP6 (Roche) or T3 polymerase (Applied Biosystems, Foster City, CA) and were purified using the RNeasy Mini Kit.
4.7.
Cell tracing experiment and confocal microscopic analysis One-cell stage embryos were injected with 0.5 nl of 1.5% 4,5-dimethoxy-2-nitrobenzyl (DMNB)-caged fluorescein-dextran (M r 3000, Molecular Probes, Eugene, OR) and 4 ng of the b4GalT2 MO or control MO. The embryos were then grown in the dark until the shield stage. To uncage the dye, a beam of ultraviolet light (k = 364 nm) generated using a FITC filter set was directed for 5 s at the dorsal or lateral blastoderm margin (Kozlowski et al., 1997; Sepich et al., 2000) . The location of the cells containing the uncaged fluorescein-dextran was monitored by observation using a stereomicroscope Leica MZ16FA fitted with a Leica DFC 500 camera (Leica Microsystems, Wetzlar, Germany) and recorded at the indicated stages. For confocal microscopic analyses, the embryos were observed using the Fluoview system (OLYMPUS, Tokyo, Japan).
Transplantation experiment
The transplantation experiment was performed as described (Shimada et al., 2008) . Donor embryos were injected at the 1-cell stage either with 0.5 nl of 4% rhodamine-dextran (M r 10,000, Molecular Probes) and 4 ng of control MO or with 0.5 nl of 4% fluorescein isothiocyanate (FITC)-dextran (M r 10,000, Molecular Probes) and 4 ng of b4GalT2 MO. The donor embryos were grown until the shield stage. A small population of deep cells from each donor embryo (i.e. injected with rhodamine and control MO or FITC and b4GalT2 MO) was aspirated using a micropipette, followed by transplantation into either wild-type or b4GalT2 MO-injected host embryos at the embryonic shield. The locations of the labeled donor cells were monitored as described above.
4.9.
b-1,4-Galactosyltransferase activity assay b-1,4-Galactosyltransferase activity was measured as described previously (Oka et al., 1992; Sasaki et al., 2005) with modifications. As an acceptor substrate, asialo-agalacto-orosomucoid (AGOR) was prepared using asialo-orosomucoid (ASOR). ASOR (400 lg) was incubated with 20 mU Streptococcus b-galacatosidase (Seikagaku corporation, Tokyo, Japan) in 200 ll of 100 mM acetate buffer pH 5.5 containing 10 mM MnCl 2 for 20 min at 37˚C. Removal of the galactose residue was confirmed by reactivity loss with RCA120 lectin (data not shown), which recognizes the terminal galactose residues. The reaction mixture was incubated for 30 min at 60˚C to denature the b-galactosidase and then neutralized by the addition of 30 ll of 1 M Tris-HCl, pH 8.5. To prepare the enzyme sources, control MO-and b4GalT2 MO-injected embryos were collected at the bud stage and dechorionated. The yolk was removed by pipetting in a balanced salt solution for medaka (Iwamatsu and Onitake, 1983) , and the embryos were transferred into extraction buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% deoxycholate and protease inhibitors). The proteins were extracted from the embryonic tissue in the buffer. After centrifugation at 15,000g for 10 min, the resultant supernatant was used as an enzyme source. An equivalent amount of each enzyme solution was incubated at 37˚C for 2 h in a 50-ll reaction mixture comprising 20 ll of the acceptor substrate, AGOR as described above, 100 lM UDP-[ 14 C]-galactose (200,000 dpm). After incubation, the assay mixture was spotted onto a 2.5-cm Whatman No.1 disc. The disc was washed with a 10% trichloroacetic acid solution three times, followed by with ethanol/ether (2:1, v/v) and then with ether. The disc was dried, and the radioactivity was counted with a liquid scintillation counter.
